Home /
Treatment Details – 15.0 months
|
|
| Description: |
| Patients: This Phase II study involved 31 patients with malignant pleural mesothelioma. Treatment: The treatment consisted of the injection of human recombinant Interleukin-2 (Proleukin). Toxicity: Grade 3 toxicities included cardiac failure and fever. Grade 2 toxicities included neuropathy, neurologic, and gastrointestinal. Results: Median overall survival was 15 months. Correspondence: Bruno Castagneto, MD |
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."